⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

ILMN · Illumina, Inc.

$189.47 latest stored close
Detected setup Wyckoff SOS

Watch · Quality 22/100

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about ILMN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / ILMN

$ILMN

Illumina, Inc.

Illumina, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $29B.

Strong Buy · 87 Health Technology Medical Specialties stock Stage 2 · Advancing Base 2 Data 11m ago
$189.47 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Thursday, July 30, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

ILMN-2.38%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. ILMN was -2.89 points vs XLV. -2.40 points vs SPY.
CatalystUnavailable Stock reactionNegative Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $189.47 Jul 27 close
52W High $199.14 -4.9%
52W Low $88.00
Wks Since High 0w
Base Depth -5.3%
Base B2
SMA 50 $170.84
SMA 200 $137.61
Avg Vol 1,874,735
RS Rank 95
RS vs High -3.9%
RS Slope +4.9% ▲
Grp Rank #47/64
ADR% 3.7%
ATR(14) $7.06 (3.7%)
Rel Vol (today) 0.93×
Vol Pace N/A
U/D Vol 1.21
A/D Days 20A / 8D
A/D Rating A+
VDU Bars 0/10 d
Power Trend 30d
Earnings 2d
$88.00
$199.14 91%

ILMN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for ILMN.

Create Free Account
Setup Quality B+ 5/7 signals
Jul 24: 70 (MA Pullback)Jul 27: 88 (Trend Only)Jul 28: 70 (Wyckoff SOS)70 Score trend
✓ Stage 2 · Advancing ✓ Power Trend 30d ✗ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 71.7 (B) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$ILMN · $189.47 · as of 2026-07-27 · multi-factor read
87
/ 100
Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$170.84 ↑
100-day$149.62 ↑
200-day$137.61 ↑
Bullish (50 > 200)

RSI (14)

Reading56.1 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-0.945

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width52% · 10.4%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.21 · Neutral
Rel volume0.93×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $196.66swing level
R · $199.1452-week high
Price · $189.47now
S · $157.63swing level
S · $155.55swing level
S · $137.00swing level

Fibonacci · Uptrend swing

23.6%$178.73
38.2%$166.10
50.0%$155.89
61.8%$145.69
78.6%$131.16

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ILMN — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 92 (leader)
Want this read in a legend's voice? 💬 Ask a Legend about ILMN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B

Trend-template read: 9/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $189.47, MA150 $144.79, MA200 $137.61
1.2 150-day MA > 200-day MAMA150 $144.79 vs MA200 $137.61
Failing evidence
2. Quarterly EPS growth ≥ 25%-14.8% QoQ
2. Revenue growth ≥ 20% YoY-0.7% YoY
9/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 92
A: Annual earnings & revenue qualityRev -0.7% | ROE 34.0%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-14.8% QoQ
S: Volume ≥ 40% above average on breakoutVolume ratio 0.93x
4/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $189.47 vs MA200 $137.61
Failing evidence
Volume expansion above averageVolume ratio 0.93x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$189.47
Relative strengthRS 92
Failing evidence
Volume vs average0.93x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$189.47
Relative strengthRS 92
Failing evidence
Volume vs average0.93x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$189.47
Relative strengthRS 92
Failing evidence
Volume vs average0.93x
Sign of Strength confirmed on expanding volume0.93x average volume — needs ≥1.4x
4/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
149RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +10 A+
A: 22 D: 12 Net: +1065 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 5/7 met
B 5/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ -15%
Revenue growth ≥20% YoY -1%
Gross margin ≥30% 67%
ROE ≥17% 34%
RS rating ≥80 (leadership) 92
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -4.9%

Method Playbook

📋 Trade it like Wyckoff EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Wyckoff SOS ⚠ Extended past buy zone ⚠ 3rd-stage base ⚠ Bearish RSI divergence
70.0 score
RS Score 92
Trend 8/8
CANSLIM 71.7* (B)
range low: 117.152 range high: 142.581 range pct: 0.217 sos thrust: 0.323 sos vol ratio: 1.631 sos bars ago: 16 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS

SOS: breakout above range_high=142.58, thrust=32.3%, vol=1.6x avg, lps=extended, 16 bars ago | Strong trend (8/8) | Top RS (92) | High-confidence pattern (70%) | Power Trend | Stage 2 | Readiness 65/100 (watch) | CANSLIM 71.7 (B) | ⚠ Extended past buy zone; 3rd-stage base; Bearish RSI divergence

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $189.47 vs SMA150 $144.79 / SMA200 $137.61
SMA 150 above SMA 200 SMA150 $144.79 vs SMA200 $137.61
SMA 200 trending up Slope +9.07 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $170.84
Price above SMA 50 $189.47 vs SMA50 $170.84
30%+ above 52W low +115.3% from $88.00
Within 25% of 52W high -4.9% from $199.14
RS score above 70 RS 92

Fundamentals

52W Range
91%
Mkt Cap SEC
28.7B
EPS QoQ
-15%
Rev YoY
-1%
ROE
34%
Gross Margin
67%
D/E
0.73
EPS TTM
$5.45
P/E TTM
34.8x
Float
151M
Insider
No Buy

Company

Legend AI snapshot
Illumina, Inc.
ILMN · NASDAQ · Health Technology · Medical Specialties
$189.47latest close $28.7Bmarket cap 95RS rank 70setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 71.7* CANSLIM * disqualified on C, M
C · Curr. EPS
33
A · Annual EPS
78
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
92
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$112.65
W. Resist
$199.14
Weekly Structure

Scan History

20× streak
Jul 24: 70 (MA Pullback)Jul 27: 88 (Trend Only)Jul 28: 70 (Wyckoff SOS)70
Jul 28
Wyckoff SOS ✓ Gate
70
Jul 27
Trend Only ✓ Gate
88 0.0%
Jul 24
MA Pullback ✓ Gate
70 -2.4%

Get the full picture on ILMN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial